Previous Page  16 / 41 Next Page
Information
Show Menu
Previous Page 16 / 41 Next Page
Page Background

Page 66

Notes:

conferenceseries

.com

Volume 5, Issue 3 (Suppl)

Mod Chem Appl, an open access journal

ISSN: 2329-6798

Global Chemistry 2017

September 04-06, 2017

September 04-06, 2017 | London, UK

5

th

Global Chemistry Congress

Synthesis of coumarin-tagged 1,3,4 oxadiazole conjugates

Sanjeev Dhawan, Srikanth Babu Jonnalagadda

and

Parvesh Singh

University of KwaZulu Natal, South Africa

C

oumarins are an important class of heterocyclic compounds with natural and synthetic origins. It has a unique benzo-

α-pyrone which has demonstrated proliferative biological activity. Similarly, the 1,3,4-oxadiazole heterocycles exhibit

remarkable pharmacological and biological properties, e.g., antibacterial, anti-viral, anti-cancer, anti-coagulation and anti-

inflammatory activities. The 1,3,4-oxadiazole ring is highly lipophilic thus improving drug permeability across cell membranes,

ensuring the drug reaches the biological target. Both classes of compounds form valuable leads in drug discovery i.e. coumarin

fused 1,3,4-oxadiazole and their derivatives. Molecular hybridization techniques have been used in drug design and discovery.

The method involves the combination of two or more bioactive pharmacophores to generate a single molecular scaffold with

improved affinity and bioactivity, in comparison to the parent molecules. Accordingly, a series of novel 7-((5-mercapto-1,3,4-

oxadiazol-2-yl)methoxy)-4,5-dimethyl-2H-chromen-2-one derivatives was synthesized. Using commercially available orcinol

as the starting material, the key intermediate 7-((5-mercapto-1,3,4-oxadiazol-2-yl)methoxy)-4,5-dimethyl-2H-chromen-2-

one was synthesized in four steps: condensation; esterification; hydrazidation and; cyclization; followed by alkylation and

benzylation.

Biography

Sanjeev Dhawan is a PhD candidate at University of KwaZulu-Natal, School of Physics and Chemistry, Westville, Durban, South Africa. He was awarded the NRF-

TWAS fellowship in 2016, to complete his PhD research in Medicinal Chemistry. He completed his B Pharmacy at Punjab Technical University, India. He completed

his M Pharmacy in Medicinal Chemistry from Lovely Professional University, Punjab in 2013. He has worked as Research Associate in Jubilant Chemsys, Noida,

India.

sanjeev.dhawan87@gmail.com

Sanjeev Dhawan et al., Mod Chem Appl 2017, 5:3(Suppl)

DOI: 10.4172/2329-6798-C1-006